Track the Quantum BioPharma Ltd. stock price and the full management transaction log of the company, a listed issuer based in Canada. Shares are quoted on the CA market, under the supervision of SEDI. The latest transaction was disclosed on 25 August 2026 (50 - Grant of options). Among the most active insiders: Carroll, Donal. All data is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer·Executives·
400,000 shares@ CA$4.80100.0% of flowOptionsTSXSEDI:4768167
5 of 5 declarations
About Quantum BioPharma Ltd.
Quantum BioPharma Ltd. is a biopharmaceutical company focused on developing innovative treatments for serious diseases. It is listed on the Toronto Stock Exchange (XTSE).